These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70. Bismuth salts and neurotoxicity. A randomised, single-blind and controlled study. Noach LA; Eekhof JL; Bour LJ; Posthumus Meyjes FE; Tytgat GN; Ongerboer de Visser BW Hum Exp Toxicol; 1995 Apr; 14(4):349-55. PubMed ID: 7598995 [TBL] [Abstract][Full Text] [Related]
71. Anti-Helicobacter pylori agents endowed with H2-antagonist properties. Sorba G; Bertinaria M; Di Stilo A; Gasco A; Scaltrito MM; Brenciaglia MI; Dubini F Bioorg Med Chem Lett; 2001 Feb; 11(3):403-6. PubMed ID: 11212121 [TBL] [Abstract][Full Text] [Related]
72. Combined activity of trospectomycin and colloidal bismuth subcitrate against Helicobacter pylori in vitro. Vogt K; Rodloff AC; Hahn H Infection; 1991; 19(3):138-9. PubMed ID: 1832417 [TBL] [Abstract][Full Text] [Related]
73. Gastroprotective effect of MX1 (a novel salt of the active metabolite of roxatidine with a complex of bismuth and citric acid) against stress ulcers in rats. Marazova K; Klouchek E; Popov A; Ivanov CH; Krushkov I J Pharm Pharmacol; 1997 Aug; 49(8):791-5. PubMed ID: 9379358 [TBL] [Abstract][Full Text] [Related]
74. A proteomic approach for the identification of bismuth-binding proteins in Helicobacter pylori. Ge R; Sun X; Gu Q; Watt RM; Tanner JA; Wong BC; Xia HH; Huang JD; He QY; Sun H J Biol Inorg Chem; 2007 Aug; 12(6):831-42. PubMed ID: 17503094 [TBL] [Abstract][Full Text] [Related]